ScreenerHero

ALA Arovella Therapeutics Limited

ASX · AU · Healthcare · Biotechnology · arovella.com
—Mkt Cap: —P/E: —

Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-gen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value31.85M USD
Revenue (TTM)2.42M USD
Gross Profit2.42M USD
Net Income (TTM)-4.78M USD
Revenue/Share0.0030 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000182784
Valuation
P/E (Trailing)—
P/E (Forward)-5.00
PEG—
EV/EBITDA-6.07
EV/Revenue13.18
P/S17.28
P/B4.17
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-1874.73%
EBITDA Margin-217.22%
Profit Margin-197.72%
ROE-48.87%
ROA-46.08%
Growth
Revenue Growth34746.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.77M USD
CapEx (TTM)27.14K USD
FCF Margin-140.93%
FCF Yield—
Net Debt-9.92M USD
Net Debt/EBITDA1.89
Balance Sheet
Debt/Equity—
Current Ratio17.51
Quick Ratio17.27
Book Value/Sh0.01 AUD
Cash/Share0.01 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateNov 14, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.21B
Float927.79M
Insiders23.48%
Institutions17.35%
Technical
SMA 500.0575 AUD
SMA 2000.0713 AUD
Beta0.17
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)852.36K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—